Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels
BackgroundHaemostasis is a crucial process by which the body stops bleeding. It is achieved by the formation of a platelet plug, which is strengthened by formation of a fibrin mesh mediated by the coagulation cascade. In proinflammatory and prothrombotic conditions, multiple interactions of the comp...
Main Authors: | Murielle Golomingi, Jessie Kohler, Christina Lamers, Richard B. Pouw, Daniel Ricklin, József Dobó, Péter Gál, Gábor Pál, Bence Kiss, Arthur Dopler, Christoph Q. Schmidt, Elaissa Trybus Hardy, Wilbur Lam, Verena Schroeder |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1226832/full |
Similar Items
-
Complement lectin pathway components MBL and MASP-1 promote haemostasis upon vessel injury in a microvascular bleeding model
by: Murielle Golomingi, et al.
Published: (2022-08-01) -
Components of the Lectin Pathway of Complement in Solid Tumour Cancers
by: Maciej Cedzyński, et al.
Published: (2022-03-01) -
Proteins of the lectin pathway of the complement system activation: immunobiological functions, genetics and involvement in the pathogenesis of human diseases
by: Marina V. Smolnikova, et al.
Published: (2022-05-01) -
Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases
by: József Dobó, et al.
Published: (2018-08-01) -
Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases
by: Katherine eLintner, et al.
Published: (2016-02-01)